Response to: Graves disease in HIV-infected patients
Saved in:
Main Author: | Chutintorn Sriphrapradang |
---|---|
Other Authors: | Faculty of Medicine, Ramathibodi Hospital, Mahidol University |
Format: | Letter |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/60397 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Characteristics of Graves disease in HIV-infected patients on antiretroviral therapy
by: Vitvala Jariyawattanarat, et al.
Published: (2020) -
Graves’ disease following SARS-CoV-2 vaccination
by: Chutintorn Sriphrapradang, et al.
Published: (2022) -
Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
by: Chutintorn Sriphrapradang
Published: (2022) -
2021 Asia-Pacific Graves’ Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves’ Disease
by: Parameswaran R.
Published: (2023) -
Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset graves' disease
by: Ouyporn Panamonta, et al.
Published: (2018)